Controversies in the management of stage III non-small-cell lung cancer.

about

Controversies in the management of stage III non-small-cell lung cancer.

Item

http://www.wikidata.org/entity/Q38176433

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Controversies in the management of stage III non-small-cell lung cancer.

@en

type

Item

label

Controversies in the management of stage III non-small-cell lung cancer.

@en

prefLabel

Controversies in the management of stage III non-small-cell lung cancer.

@en

P1476

Controversies in the management of stage III non-small-cell lung cancer.

@en

P2093

Neelesh Sharma

http://www.w3.org/2001/XMLSchema#string

Tithi Biswas

http://www.w3.org/2001/XMLSchema#string

P2860

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

Erlotinib in previously treated non-small-cell lung cancer

Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial

Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.

Postoperative radiotherapy in non-small-cell lung cancer: update of an individual patient data meta-analysis.

Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage IIIB non-small-cell lung cancer: cancer and leukemia group B study 9431.

Weekly nab-paclitaxel in combination with carboplatin versus solvent-based paclitaxel plus carboplatin as first-line therapy in patients with advanced non-small-cell lung cancer: final results of a phase III trial.

Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer.

Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database.

P304

333-347

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737140.2014.867809

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Mitchell Machtay

P577

2014-01-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24397773

http://www.w3.org/2001/XMLSchema#string